Streetbeat News

ADYEY

Adyen NV

https://www.adyen.com/

CEO

Pieter van der Does

Industry

Financial Transactions Processing, Reserve, and Clearinghouse Activities

Open

14.79

Mkt cap

47B

Volume

80K

High

15.04

P/E Ratio

53.29

52-wk high

17.27

Low

14.77

Div yield

N/A

52-wk low

10.78

Adyen reported a 21% increase in third-quarter net revenue, reaching 498.3 million. This follows a significant drop in Adyen's share price last August due to disappointing sales and profits.

Portfolio Pulse from

November 07, 2024 | 7:15 am

The article provides a detailed guide on how to analyze a company's quarterly earnings report, emphasizing its importance for investors, analysts, and consumers. It also highlights the different purposes of these reports, including investment decisions, analyst assessments, and consumer impact. The article uses Texas Instruments Incorporated (NASDAQ:TXN) as an example to illustrate the process.

Portfolio Pulse from Dave Ahern

September 20, 2023 | 7:55 pm

Dutch payment technology company Adyen (OTC:ADYEY) has been granted a banking license in the UK, allowing it to offer cash advances to small and medium-sized enterprises. The license also enables Adyen to continue offering its recently launched financial product suite in the UK. Cathie Wood's ARK Invest recently purchased shares of Adyen through ARK Fintech Innovation ETF (NYSE:ARKF) and ARK Next Generation Internet ETF (NYSE:ARKW).

Portfolio Pulse from Khyathi Dalal

September 07, 2023 | 11:03 pm

Ark Invest, led by Cathie Wood, sold $9.2 million worth of Shopify Inc (NYSE:SHOP) shares due to recent volatility following its Q2 results. The shares were sold through ARK Next Generation Internet ETF (NYSE:ARKW) and Ark Fintech Innovation ETF (NYSE:ARKF). Ark Invest also bought shares of ADYEN NV (OTC:ADYEY), CRISPR THERAPEUTICS AG (NASDAQ:CRSP), ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT), and RECURSION PHARMACEUTICALS (NASDAQ:RXRX), and sold shares of CODEXIS INC (NASDAQ:CDXS) and PHENOMEX INC (NASDAQ:CELL).

Portfolio Pulse from Benzinga Neuro

August 22, 2023 | 2:27 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.